About
Dr. Dana Bliuc is a clinical epidemiologist at the University of New South Wales (UNSW), specializing in fracture epidemiology with a focus on osteoporotic fractures and their long-term outcomes. Her work emphasizes understanding adverse events post-fracture and evaluating the safety and efficacy of osteoporosis treatments in real-world settings. She holds expertise in clinical epidemiology, biostatistics, and pharmacoepidemiology, contributing to advancements in fracture prevention strategies.
Her research spans over 15 years, including foundational PhD work demonstrating the high risk of long-term adverse events and premature mortality linked to osteoporotic fractures. She has collaborated on large-scale studies such as the Dubbo Osteoporosis Epidemiology Study and the Canadian Multicentre Osteoporosis Study (CaMos). Her work frequently addresses multimorbidity, mortality risk stratification, and the interplay between bone health and chronic conditions like diabetes.
Dr. Bliuc’s publications highlight her contributions to understanding fracture risk assessment, the impact of interventions like bariatric surgery, and the role of muscle strength in predicting fractures. She has authored over 67 journal articles, 4 book chapters, and numerous conference presentations, reflecting her active role in advancing clinical and public health research.
